Obstetrics and Gynecology Update 2021 - Exhibitor: Ferring Pharmaceuticals

Obstetrics and Gynecology Update: What Does The Evidence Tell Us?
Course# MOB22001
October 13 - 15, 2021

ferring Logo

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. With global headquarters in Saint-Prex, Switzerland and its US Operations Center in Parsippany, NJ, Ferring is a leader in Reproductive Medicine and Maternal Health, and in specialty areas within Gastroenterology and Orthopaedics. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.


Resources

Learn more about Menopur

Learn more about Endometrin

Commitment video

Social Media Links: Twitter


For more information, please contact:

Josie Bender
[email protected]
724-261-0922

 

Return to Virtual Exhibit Hall